Cytokinetics
CYTK
CYTK
211 hedge funds and large institutions have $3.11B invested in Cytokinetics in 2021 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 97 increasing their positions, 45 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
60% more funds holding in top 10
Funds holding in top 10: 5 → 8 (+3)
11% more funds holding
Funds holding: 190 → 211 (+21)
2.7% more ownership
Funds ownership: 105.38% → 108.08% (+2.7%)
Holders
211
Holding in Top 10
8
Calls
$16.7M
Puts
$5.69M
Top Buyers
| 1 | +$143M | |
| 2 | +$57.5M | |
| 3 | +$52.6M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$35.7M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$35.7M |
Top Sellers
| 1 | -$39.3M | |
| 2 | -$14.3M | |
| 3 | -$14.1M | |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
-$13.9M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
-$13.4M |